Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis

BMJ 2011; 342 doi: http://dx.doi.org/10.1136/bmj.c7086 (Published 11 January 2011)
Cite this as: BMJ 2011;342:c7086

Related articles

Research: Non-steroidal anti-inflammatory drug use and risk of atrial fibrillation or flutter: population based case-control study

Letter: Results can be summarised in a simple figure

Research: All cause and disease specific mortality in patients with knee or hip osteoarthritis: population based cohort study

Editorial: Cardiovascular safety of NSAIDs

Fillers: Do selective cyclo-oxygenase-2 inhibitors and traditional non-steroidal anti-inflammatory drugs increase the risk of atherothrombosis? Meta-analysis of randomised trials

Education and debate: Simultaneous comparison of multiple treatments: combining direct and indirect evidence

Paper: Bias in meta-analysis detected by a simple, graphical test

Paper: Statistics notes: Absence of evidence is not evidence of absence

See more

Practice: Investigating microcytic anaemia

News: Study links drugs for Alzheimer’s disease with reduced risk of heart attack and death

News: High dose NSAIDs may double the risk of heart attacks and heart failure, says new study

Practice: Opioids for chronic non-cancer pain

Letter: First do no harm with anti-obesity and other drugs

This article has been cited by other articles:

THIS WEEK'S POLL